Advanced assistance technologies, if made available and sustainable, can represent a turning point for the quality of life of ...

Incomplete and ambiguous ethnicity category labels limited equity-focused analyses ... Initially, services were for monitoring patients with stable glaucoma, age-related macular degeneration and ...

Age-Related Macular Degeneration Market Epidemiology Report 2025-2035: Drugs Pipeline, Therapies, and Forecast The report provides a detail ...

Sanofi's SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration <li /> Designat ...

How you prepare your morning cup of joe could be linked to an eye disease that affects nearly 20 million Americans.

Age-related macular degeneration (AMD), classified into dry and wet types, poses a significant threat to the vision of the ...

Sanofi said SAR446597, its treatment for geographic atrophy due to age-related macular degeneration, was granted fast-track designation by the Food and Drug Administration. The French drugmaker said ...

The FDA granted fast track designation to SAR446597, an intravitreal gene therapy for the treatment of geographic atrophy due to age-related macular degeneration, according to a press release from ...

The US Food and Drug Administration (FDA) recently granted fast track designation to Sanofi’s SAR446597 for the treatment of geographic atrophy (GA). 1 ...

Macular degeneration articles from across Nature Portfolio Macular degeneration usually refers to the age-related degenerative changes in the retina that can result in loss of central vision.